Libya vs Saint Vincent and the Grenadines: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology

Libya
0.2%
in 2024
Saint Vincent and the Grenadines
0.2%
in 2024
Libya rank
98th
Saint Vincent and the Grenadines rank
98th

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time

  • Libya
  • Saint Vincent and the Grenadines
00.10.20.30.4201520192024

How they compare

Libya currently reports 0.2% against 0.2% in Saint Vincent and the Grenadines, a difference of 0.0%.

Across all 10 years both countries report, Saint Vincent and the Grenadines has been ahead every year.

Libya ranks 98th and Saint Vincent and the Grenadines ranks 98th of 246 countries.

Saint Vincent and the Grenadines has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Libya Saint Vincent and the Grenadines Difference Ahead
2010s 0.2% 0.3% 0.1% Saint Vincent and the Grenadines
2020s 0.2% 0.2% 0.0%

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Libya or Saint Vincent and the Grenadines?
Libya, at 0.2% against 0.2% in Saint Vincent and the Grenadines as of 2024.
What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Libya and Saint Vincent and the Grenadines?
0.0%, with Libya ahead.
How many years of comparable data are there for Libya and Saint Vincent and the Grenadines?
10 years are reported by both, from 2015 to 2024.
How do Libya and Saint Vincent and the Grenadines rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Libya ranks 98th and Saint Vincent and the Grenadines ranks 98th of 246 countries.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Libya vs Saint Vincent and the Grenadines: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 05 September 2026, from https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/libya/st-vincent-and-the-grenadines/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/libya/st-vincent-and-the-grenadines/">Libya vs Saint Vincent and the Grenadines: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Unit
%
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
250 places, 2,500 data points, 2015–2024
Last refreshed